These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29277475)
1. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA. Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475 [TBL] [Abstract][Full Text] [Related]
2. Computational screening of potential drug targets for pathogens causing bacterial pneumonia. Nayak S; Pradhan D; Singh H; Reddy MS Microb Pathog; 2019 May; 130():271-282. PubMed ID: 30914386 [TBL] [Abstract][Full Text] [Related]
4. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets. Uddin R; Sufian M PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565 [TBL] [Abstract][Full Text] [Related]
5. Duguma T; Dinka H Biomed Res Int; 2024; 2024():5917667. PubMed ID: 38283072 [No Abstract] [Full Text] [Related]
6. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Lynch JP; Zhanel GG Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783 [TBL] [Abstract][Full Text] [Related]
7. The approach to treatment of invasive pneumococcal disease in the 1990s. Knapp KM; Schutze GE J Ark Med Soc; 1997 Nov; 94(6):263-6. PubMed ID: 9392928 [TBL] [Abstract][Full Text] [Related]
8. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media. Keller LE; Bradshaw JL; Pipkins H; McDaniel LS Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973 [TBL] [Abstract][Full Text] [Related]
9. [Streptococcus pneumoniae and beta-lactam antibiotic agents]. Ranin L; Vucković-Opavski N; Berger-Jekić O Srp Arh Celok Lek; 1996; 124(1-2):18-23. PubMed ID: 9102809 [TBL] [Abstract][Full Text] [Related]
10. Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance. Allan RN; Morgan S; Brito-Mutunayagam S; Skipp P; Feelisch M; Hayes SM; Hellier W; Clarke SC; Stoodley P; Burgess A; Ismail-Koch H; Salib RJ; Webb JS; Faust SN; Hall-Stoodley L Antimicrob Agents Chemother; 2016 Apr; 60(4):2456-66. PubMed ID: 26856845 [TBL] [Abstract][Full Text] [Related]
11. Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation. Chen HH; Stringer A; Eguale T; Rao GG; Ozawa S Am J Trop Med Hyg; 2019 Nov; 101(5):1042-1053. PubMed ID: 31516111 [TBL] [Abstract][Full Text] [Related]
12. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention. Harwell JI; Brown RB Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700 [TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Woolfson A; Huebner R; Wasas A; Chola S; Godfrey-Faussett P; Klugman K Bull World Health Organ; 1997; 75(5):453-62. PubMed ID: 9447779 [TBL] [Abstract][Full Text] [Related]
14. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Liñares J; Ardanuy C; Pallares R; Fenoll A Clin Microbiol Infect; 2010 May; 16(5):402-10. PubMed ID: 20132251 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg. Huebner RE; Wasas AD; Klugman KP; S Afr Med J; 2000 Nov; 90(11):1116-21. PubMed ID: 11196033 [TBL] [Abstract][Full Text] [Related]
16. Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm. Dagan R; Barkai G; Leibovitz E; Dreifuss E; Greenberg D Pediatr Infect Dis J; 2006 Oct; 25(10):981-6. PubMed ID: 17006311 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network. Kempf M; Baraduc R; Bonnabau H; Brun M; Chabanon G; Chardon H; Croizé J; Demachy MC; Donnio PY; Dupont P; Fosse T; Gibel L; Gravet A; Grignon B; Hadou T; Hamdad F; Joly-Guillou ML; Koeck JL; Maugein J; Péchinot A; Ploy MC; Raymond J; Ros A; Roussel-Delvallez M; Segonds C; Vergnaud M; Vernet-Garnier V; Lepoutre A; Gutmann L; Varon E; Lanotte P Microb Drug Resist; 2011 Mar; 17(1):31-6. PubMed ID: 20809835 [TBL] [Abstract][Full Text] [Related]
19. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin. León-Sicairos N; Angulo-Zamudio UA; Vidal JE; López-Torres CA; Bolscher JG; Nazmi K; Reyes-Cortes R; Reyes-López M; de la Garza M; Canizalez-Román A Biometals; 2014 Oct; 27(5):969-80. PubMed ID: 25053107 [TBL] [Abstract][Full Text] [Related]
20. [An update of Streptococcus pneumoniae: from genomic to clinic]. Wintenberger C Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286 [No Abstract] [Full Text] [Related] [Next] [New Search]